SCHEMBL3659347

SCHEMBL3659347

Cc1ccc(-c2cc(C(=O)O)cc(N3CCOCC3)c2)c(F)c1

nearest known ligand 0.49

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KMO O15229 1/20 0.49
HPGD P15428 3/20 0.46
ALDH1A1 P00352 2/20 0.46
LMNA P02545 2/20 0.46
SMN1; SMN2 Q16637 2/20 0.46
RORC P51449 1/20 0.44
P2RX3 P56373 2/20 0.43
P2RX2 Q9UBL9 2/20 0.43
NPC1 O15118 2/20 0.42
TP53 P04637 2/20 0.42
MAPK1 P28482 2/20 0.42
RAB9A P51151 2/20 0.42
PKM P14618 1/20 0.42
AKR1C3 P42330 1/20 0.40
RAF1 P04049 1/20 0.40
BRAF P15056 1/20 0.40
MAPT P10636 2/20 0.40
MEN1 O00255 2/20 0.40
KMT2A Q03164 2/20 0.40
KDM4E B2RXH2 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3058541 0.80 KMO (0.56) KMOHPGDALDH1A1LMNAMAPK1
SCHEMBL2260307 0.77 PIK3CA (0.50) HPGDALDH1A1LMNASMN1; SMN2MAPK1
SCHEMBL13095560 0.77 P2RX3 (0.46) HPGDALDH1A1LMNASMN1; SMN2P2RX3
SCHEMBL3071009 0.76 P2RX3 (0.47) LMNAP2RX3P2RX2RAF1BRAF
SCHEMBL3805195 0.76 P2RX3 (0.47) LMNAP2RX3P2RX2RAF1BRAF
SCHEMBL27893364 0.75 KMO (0.70) KMOHPGDALDH1A1LMNASMN1; SMN2
SCHEMBL358004 0.74 NOTUM (0.43) ALDH1A1SMN1; SMN2P2RX3P2RX2TP53
SCHEMBL593762 0.74 KMO (0.60) KMOHPGDALDH1A1SMN1; SMN2NPC1
SCHEMBL4320091 0.74 LMNA (0.41) LMNAP2RX3P2RX2TP53AKR1C3
SCHEMBL16195521 0.73 DHODH (0.52) KMOHPGDLMNASMN1; SMN2AKR1C3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2215049-B1 P2X3, RECEPTOR ANTAGONISTS FOR TREATMENT OF PAIN MERCK SHARP & DOHME (US) 2019-06-12 EP disclosed
US-8247401-B2 P2X3 receptor antagonists for treatment of pain MERCK SHARP & DOHME CORP. (US) 2012-08-21 US disclosed
EP-2215049-A1 P2X3, RECEPTOR ANTAGONISTS FOR TREATMENT OF PAIN Merck Sharp & Dohme Corp. (US) 2010-08-11 EP disclosed
WO-2009058298-A1 P2X3, RECEPTOR ANTAGONISTS FOR TREATMENT OF PAIN MERCK & CO., INC. (US) 2009-05-07 WO disclosed